Providers are up to three times more likely to trust the opinion of humans over AI, even when the algorithm is proven to detect more cancerous lesions than radiologists. 

Imaging might not drive as many treatment adjustments as previously believed, according to a new meta-analysis.

A new study focuses on the role oxalic acid may play in the body’s ability to eliminate gadolinium after an MRI study.

Currently there are no FDA cleared echocardiography contrast agents commercially available for use on the right side of the heart to detect shunts, but a new agent that promises to improve workflow and imaging is about to enter a U.S. trial. 

Researchers at Oregon State University are working on developing a way to make contrast agents more targeted. 

Even with thorough treatment and surgery, women with a personal history of breast cancer are at increased risk of developing second cancers in the future. 

Diagnostic Imaging of Southbury recently asked for permission to buy a second MR system, with its first currently operating at 120% capacity. 

The tool extracts brain region and white matter lesion volumes from any MRI of the brain, even less specialized sequences not traditionally used in the diagnosis or management of MS.